FDA Approves Adaptive DBS for Parkinson’s Patients
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms. Unlike traditional DBS, which delivers constant stimulation, aDBS monitors brain activity and responds with precise electric pulses to prevent stiffness and involuntary movements.
